Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Neurology, Neurosurgery, and Psychiatry 2005;76:739-741; doi:10.1136/jnnp.2004.051847
Copyright © 2005 by the BMJ Publishing Group Ltd.
Journal of Neurology Neurosurgery and Psychiatry 2005;76:739-741
© 2005 BMJ Publishing Group Ltd

SHORT REPORT

The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland

S S M Razvi1, R Davidson2, I Bone1 and K W Muir1

1 Division of Clinical Neurosciences, Institute of Neurological Sciences, Southern General Hospital, 1345 Govan Road, Glasgow, G51 4TF, Scotland
2 West of Scotland Regional Genetics Service, Glasgow, G3 8SJ, Scotland

Correspondence to:
Correspondence to:
Keith Muir
Senior Lecturer, Institute of Neurological Sciences, Southern General Hospital, 1345 Govan Road, Glasgow, G3 8QB, Scotland; k.muir{at}clinmed.gla.ac.uk

ABSTRACT

Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) is caused by mutations of the Notch3 gene on 19p13. Varying phenotypic expression leads to under recognition and misdiagnosis. Prevalence therefore remains uncertain. We sought to estimate the prevalence of CADASIL in the west of Scotland.

Methods: A register for CADASIL was established at a regional neurosciences centre in 2002. All patients with genetically (exons 3, 4, 5, and 6) or histologically confirmed CADASIL residing in two defined administrative health areas were identified. Pedigree members at varying risk of carrying the mutation were also identified and the number of probable Notch3 mutation carriers in the defined population was predicted. Prevalence was calculated for definite CADASIL cases, with and without probable carrier numbers, based upon adult population figures from the 2002 national census.

Results: Twenty two individuals from seven pedigrees with confirmed CADASIL and resident in the defined geographical area were identified, yielding a prevalence of 1.98 (95% confidence interval 1.24–3.00) per 100 000 adults. An additional 37 individuals were predicted to be carriers of the Notch3 mutation, yielding a probable mutation prevalence of 4.14 (3.04–5.53) per 100 000 adults.

Conclusions: The prevalence of genetically proven CADASIL was 1.98 per 100 000 adults in the defined population. This figure underestimates disease burden.

Abbreviations: CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy; MRI, magnetic resonance imaging; PCR, polymerase chain reaction

Keywords: CADASIL; cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy; cerebrovascular disease; prevalence


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Taylor, M. H., Doody, G. A. (2008). CADASIL: a guide to a comparatively unrecognised condition in psychiatry. Adv. Psychiatr. Treat. 14: 350-357 [Abstract] [Full Text]  
  • Chui, H., Skoog, I. (2006). Advances in Vascular Cognitive Impairment 2005. Stroke 37: 323-325 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs

Neurology and neurosurgery jobs